Jingjing Qian

Jingjing Qian is an Associate Professor in the Department of Health Outcomes Research and Policy at Auburn University's Harrison College of Pharmacy. She holds advanced degrees in Pharmaceutical Administration, Social & Administrative Sciences in Pharmacy, Epidemiology, and Pharmacoepidemiology.

• B.S., Pharmaceutical Administration - China Pharmaceutical University, 2001
• M.S., Social & Administrative Sciences in Pharmacy - University of Cincinnati, 2006
• M.S., Epidemiology - University of Maryland, 2012
• Ph.D., Pharmacoepidemiology - University of Maryland, 2012

Her research focuses on health outcomes and pharmacoepidemiology, particularly examining comparative effectiveness and safety of drug products to improve population health and reduce disparities. Current projects include cancer epidemiology (breast, prostate, lung), mental health, substance use disorder analysis, chronic condition management, and medication adherence studies. She has received multiple U.S. FDA grants for generic drug post-marketing surveillance and education initiatives.

Past funded research includes:

• $49,529 (2022) - Breast Cancer Research Foundation of Alabama (PI)
• $30,334 (2021) - Breast Cancer Research Foundation of Alabama (PI)
• $500,000 (2021-2024) - Oregon Health and Science University (Co-PI)
• $50,000 (2020) - Mike Slive Foundation (PI)
• $749,837 (2015-2019) - FDA Grant U01FD005486 (PI)
• $2,500,000 (2015-2018) - FDA Grant FDA BAA-13-0019 (Co-Investigator)
• $399,990 (2016-2018) - FDA Grant U01FD005875 (PI)

Recent publications analyze biosimilar safety, drug interactions, opioid treatment guidelines, and machine learning applications in pharmacovigilance. Current graduate students include Xiangzhong Xue and Kaniz Afroz Tanni.